Low-Dose IL-2 Reduces Lymphocyte Apoptosis and Increases Naive CD4 Cells in HIV-1 Patients Treated with HAART
- 31 March 2000
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 94 (3), 153-159
- https://doi.org/10.1006/clim.2000.4837
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Efficacy of Low‐Dose Subcutaneous Interleukin‐2 to Treat Advanced Human Immunodeficiency Virus Type 1 in Persons with ⩽250/μL CD4 T Cells and Undetectable Plasma Virus LoadThe Journal of Infectious Diseases, 1999
- In vivo analysis of Fas/FasL interactions in HIV-infected patients.Journal of Clinical Investigation, 1998
- Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.Journal of Clinical Investigation, 1997
- Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphoe from HIV-infected individualsClinical and Experimental Immunology, 1993
- CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-upAIDS, 1993
- Fibroblast-derived factors preserve viability in vitro of mononuclear cells isolated from subjects with HIV-1 infectionAIDS, 1993
- Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis.The Journal of Experimental Medicine, 1992
- Programmed Death of T Cells in HIV-1 InfectionScience, 1992
- Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.The Journal of Experimental Medicine, 1992
- Cell dysfunction and depletion in AIDS: the programmed cell death hypothesisImmunology Today, 1991